Sequential use of teriparatide and raloxifene HCl in the treatment of postmenopausal women with osteoporosis

Trial Profile

Sequential use of teriparatide and raloxifene HCl in the treatment of postmenopausal women with osteoporosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2008

At a glance

  • Drugs Raloxifene; Teriparatide
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Jan 2008 Primary endpoint results have been published
    • 11 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top